CIA
PFE icon

Compass Ion Advisors’s Pfizer PFE Stock Holding History

Compass Ion Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Buy
25,488
+3,906
+18% +$102K 0.05% 166
2026
Q1 		$606K Buy
21,582
+142
+0.7% +$3.78K 0.06% 157
2025
Q4 		$534K Sell
21,440
-616
-3% -$15.5K 0.05% 173
2025
Q3 		$562K Buy
22,056
+132
+0.6% +$3.26K 0.05% 169
2025
Q2 		$531K Sell
21,924
-1,907
-8% -$44.5K 0.06% 164
2025
Q1 		$604K Sell
23,831
-464
-2% -$12.1K 0.07% 153
2024
Q4 		$645K Buy
24,295
+8,677
+56% +$235K 0.08% 145
2024
Q3 		$452K Buy
15,618
+404
+3% +$11.8K 0.06% 173
2024
Q2 		$422K Hold
15,214
– – 0.06% 155
2024
Q1 		$422K Sell
15,214
-357
-2% -$9.91K 0.06% 156
2023
Q4 		$448K Sell
15,571
-681
-4% -$20.6K 0.07% 152
2023
Q3 		$539K Buy
+16,252
New +$575K 0.09% 135

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Compass Ion Advisors's PFE Position: Q2 2026 in Review

Compass Ion Advisors increased its Pfizer (PFE) stake by 18% in Q2 2026, buying an estimated $102K and bringing the position to 25,488 shares worth $614K. The position accounts for 0.05% of the portfolio, ranked #166.

Compass Ion Advisors first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $645K in Q4 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Compass Ion Advisors held 25,488 shares of Pfizer worth $614K as of Q2 2026.
  • Compass Ion Advisors bought 3,906 Pfizer shares in Q2 2026, an estimated $102K.
  • Pfizer made up 0.05% of Compass Ion Advisors's portfolio in Q2 2026, its #166 holding.
  • Compass Ion Advisors first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • Compass Ion Advisors's Pfizer position peaked at $645K in Q4 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.